kontoghiorghes g - Search Results

Year	Number of Results
1983	1
1985	3
1986	9
1987	10
1988	5
1989	7
1990	10
1991	4
1992	3
1993	5
1994	2
1995	4
1996	1
1997	1
2000	3
2001	3
2002	1
2003	3
2004	2
2005	5
2006	8
2007	1
2008	7
2009	6
2010	9
2011	4
2012	3
2013	8
2014	4
2015	3
2016	3
2017	3
2018	2
2019	2
2020	6
2021	0

1

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes.

Kontoghiorghe CN, Kontoghiorghes GJ. Kontoghiorghe CN, et al. Among authors: kontoghiorghes gj. Drug Des Devel Ther. 2016 Jan 29;10:465-81. doi: 10.2147/DDDT.S79458. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 26893541 Free PMC article. Review.

2

The History of Deferiprone (L1) and the Paradigm of the Complete Treatment of Iron Overload in Thalassaemia.

Kontoghiorghes GJ, Kleanthous M, Kontoghiorghe CN. Kontoghiorghes GJ, et al. Mediterr J Hematol Infect Dis. 2020 Jan 1;12(1):e2020011. doi: 10.4084/MJHID.2020.011. eCollection 2020. Mediterr J Hematol Infect Dis. 2020. PMID: 31934321 Free PMC article. Review.

3

Advances on Chelation and Chelator Metal Complexes in Medicine.

Kontoghiorghes GJ. Kontoghiorghes GJ. Int J Mol Sci. 2020 Apr 3;21(7):2499. doi: 10.3390/ijms21072499. Int J Mol Sci. 2020. PMID: 32260293 Free PMC article.

4

How to manage iron toxicity in post-allogeneic hematopoietic stem cell transplantation?

Kontoghiorghes GJ. Kontoghiorghes GJ. Expert Rev Hematol. 2020 Apr;13(4):299-302. doi: 10.1080/17474086.2020.1719359. Epub 2020 Feb 8. Expert Rev Hematol. 2020. PMID: 32037922 No abstract available.

5

Effective inhibition of copper-catalyzed production of hydroxyl radicals by deferiprone.

Timoshnikov VA, Kobzeva T, Selyutina OY, Polyakov NE, Kontoghiorghes GJ. Timoshnikov VA, et al. Among authors: kontoghiorghes gj. J Biol Inorg Chem. 2019 May;24(3):331-341. doi: 10.1007/s00775-019-01650-9. Epub 2019 Mar 13. J Biol Inorg Chem. 2019. PMID: 30868263

6

Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases.

Kontoghiorghes GJ, Kontoghiorghe CN. Kontoghiorghes GJ, et al. Cells. 2020 Jun 12;9(6):1456. doi: 10.3390/cells9061456. Cells. 2020. PMID: 32545424 Free PMC article. Review.

7

Prospects for the introduction of targeted antioxidant drugs for the prevention and treatment of diseases related to free radical pathology.

Kontoghiorghes GJ, Kontoghiorghe CN. Kontoghiorghes GJ, et al. Expert Opin Investig Drugs. 2019 Jul;28(7):593-603. doi: 10.1080/13543784.2019.1631284. Epub 2019 Jun 21. Expert Opin Investig Drugs. 2019. PMID: 31185180 Review.

8

Trying to Solve the Puzzle of the Interaction of Ascorbic Acid and Iron: Redox, Chelation and Therapeutic Implications.

Kontoghiorghes GJ, Kolnagou A, Kontoghiorghe CN, Mourouzidis L, Timoshnikov VA, Polyakov NE. Kontoghiorghes GJ, et al. Medicines (Basel). 2020 Jul 30;7(8):45. doi: 10.3390/medicines7080045. Medicines (Basel). 2020. PMID: 32751493 Free PMC article. Review.

9

New targeted therapies and diagnostic methods for iron overload diseases.

Kolnagou A, Kontoghiorghe CN, Kontoghiorghes GJ. Kolnagou A, et al. Among authors: kontoghiorghes gj. Front Biosci (Schol Ed). 2018 Jan 1;10:1-20. doi: 10.2741/s498. Front Biosci (Schol Ed). 2018. PMID: 28930516 Review.

10

Redox Interactions of Vitamin C and Iron: Inhibition of the Pro-Oxidant Activity by Deferiprone.

Timoshnikov VA, Kobzeva TV, Polyakov NE, Kontoghiorghes GJ. Timoshnikov VA, et al. Among authors: kontoghiorghes gj. Int J Mol Sci. 2020 May 31;21(11):3967. doi: 10.3390/ijms21113967. Int J Mol Sci. 2020. PMID: 32486511 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results